MetLife 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- MetLife reported 3rd quarter 2026 net income of $2.4 billion, or $3.67 per share, and adjusted earnings of $1.8 billion, or $2.78 per share, including $46 million of notable items.
- Excluding notable items, adjusted earnings were $1.8 billion, up 17%, and adjusted earnings per share were $2.85, up 22%, from a year ago; year-to-date adjusted earnings per share excluding notable items were up 22%.
- Adjusted return on equity excluding notable items was 19.6% for the quarter and above 17% year to date; adjusted book value per share rose 5% from a year ago to $59.41.
- Pretax variable investment income was $720 million, with average private equity returns of 4.2%; year-to-date variable investment income was approximately $1.5 billion.
- Group Benefits adjusted earnings excluding notable items were $523 million, up 14%; the Group Life mortality ratio was 79.5%, and the non-medical health ratio was 72.3%.
- Retirement and Income Solutions adjusted earnings excluding notable items were $478 million, up 12%; adjusted PFOs excluding pension risk transfers rose 33%, and retained liability balances increased 7%.
- Asia adjusted earnings excluding notable items were $550 million, up 21% on a constant currency basis; Latin America adjusted earnings were $229 million, and EMEA adjusted earnings were $114 million, up 30%.
- MetLife Investment Management adjusted earnings were $63 million, up 9%; total AUM was $723 billion, up 14%, including institutional client AUM of $308 billion, up 45% from a year ago.
- The direct expense ratio was 11.9%; holding company cash and liquid assets totaled $3.4 billion at quarter-end.
- MetLife repurchased $650 million of common shares in the 3rd quarter and another $265 million in October; year-to-date capital returned to shareholders was roughly $3.5 billion.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Ladies and gentlemen, thank you for standing by. Welcome to the MetLife third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will be given at that time. As a reminder, this conference is being recorded. Before we get started, I refer you to the cautionary note about forward-looking statements in yesterday's earnings release and to risk factors discussed in MetLife's SEC filings. With that, I will turn the call over to John Hall, Treasurer and Global Head of Investor Relations.
Please go ahead. Thank you, operator, and good morning, everyone.
Welcome to MetLife's third quarter 2026 earnings call. Before we begin, please review the information on non-GAAP measures in our earnings release, in our quarterly financial supplement, and in our earnings call and investor presentations, all of which can be found on the investor relations website at metlife.com. On the call today are Michel Khalaf, President and Chief Executive Officer, and John McCallion, Chief Financial Officer and Head of MetLife Investment Management. Other members of senior management are also available to participate. This morning, John will speak to the earnings call presentation we released last night on our website. An appendix to the deck features disclosures, GAAP reconciliations, and other information which you should review. After prepared remarks, we will have a Q&A session that ends at the top of the hour.
As a reminder, please limit yourself to one question and one follow-up.
Now to Michel. Thank you, John, and good morning, everyone.
The third quarter was another excellent quarter under our New Frontier strategy. We delivered MetLife's highest adjusted earnings per share quarter ever, with top-line growth across all operating segments. More importantly, the quarter extends a pattern we have demonstrated throughout the year: broad-based growth, attractive returns, and disciplined capital management. Variable investment income was a significant contributor this quarter, particularly through private equity and venture capital returns. While VII amplified the quarter, it did not define it. We also delivered strong underwriting and volume growth across the enterprise. No single business drove results. That breadth is the central strength of MetLife. Our complementary capital-light and capital-driven earnings engines allow us to create value in different ways and across different market environments. Underwriting margins, fees, and spread income generate durable earnings and recurring cash flow.
We reinvest that cash where MetLife has structural advantages and return excess capital to shareholders. The engines also reinforce one another. Our retirement businesses originate liabilities backed by long-term assets, and we use insurance and third-party capital to support that growth. MetLife Investment Management manages most of the assets, adding fee income and expanding our capital-light earnings. This efficient model helps fuel growth and generate capital to reinvest. It is a model designed to compound. Two years into New Frontier, the evidence that the strategy is working as intended is increasingly clear. Year to date, adjusted earnings per share, excluding notable items, are up 22%, with adjusted return on equity above 17%. The sources of growth vary from quarter to quarter, but the pattern is consistent: broad-based execution, attractive returns, and strong cash generation. Now to the third quarter numbers.
We reported adjusted earnings of $1.8 billion, or $2.78 per share. That includes $46 million of notable items, primarily from our annual actuarial assumption review. Excluding notable items, adjusted earnings were $1.8 billion, up 17%, and adjusted earnings per share were $2.85, up 22%, both from a year ago. Variable investment income totaled $720 million pre-tax on private equity returns of more than 4% versus 3% a year ago. Our direct expense ratio was 11.9%, on track to beat our 12.1% full-year target. Productivity is a big driver of that, and AI is a growing part of it. AI is a force multiplier for us. It's helping us grow, improve customer experience, and operate with greater speed and precision, all while holding down our ratio as we absorb the acquisition of PineBridge Investments, a structurally higher expense business.
Adjusted return on equity, excluding notable items, was 19.6%, well above our full-year 15%-17% target range. This is what compounding looks like. We earn a high return on equity, return capital to shareholders, and still grow adjusted book value per share, up 5% from a year ago to $59.41. Turning to the performance of our businesses, starting with group benefits, adjusted earnings were $523 million, excluding notables, up 14%. Life underwriting was favorable as broad-based improvement in working-age mortality continues. The group life mortality ratio was 79.5%, well below our target range. The non-medical health ratio was 72.3%, just below the midpoint of our target range. On an adjusted basis, our premiums, fees and other revenues, or PFOs, increased 5% when you exclude participating contracts, with sales up 12% year to date.
In my view, group benefits is the most attractive segment of U.S. life insurance, and MetLife is far and away best in class across the widest array of products and markets in the industry. This unparalleled scale translates to above-market growth with close to $26 billion of annual PFO. These capital-light PFOs turn into adjusted earnings with a high free cash flow conversion ratio. Moving to Retirement and Income Solutions, or RIS, adjusted earnings excluding notable items were $478 million, up 12% on higher investment margins and volume growth. Adjusted PFOs, excluding pension risk transfers, increased 33%, driven in part by U.K. longevity reinsurance, and retained liability balances were up 7%. While U.S. pension risk transfers activity has been lighter this year, we see this as timing, not a structural change.
High funding levels provide plan sponsors with execution flexibility relative to timing and structure, and the intent to de-risk remains strong, all key observations from our annual pension risk transfer poll of plan sponsors. This highlights a core strength of our retirement business, its diversified multi-channel and multi-product breadth. Alongside PRT, we are a leader across UK longevity re, UK funded re, structured settlements, stable value, corporate-owned life insurance, and we have a growing presence in U.S. retail annuity reinsurance. Our broad scope and leading positions mean we are not reliant on any single retirement market, and we are able to pivot to those opportunities that represent the highest and best use of our capital. In Asia, adjusted earnings excluding notable items were $550 million, up 21% on a constant currency basis. Results benefited from higher VII and favorable equity markets performance.
Adjusted PFOs rose 5% on a constant currency basis, with Korea continuing to show strong momentum. In Latin America, adjusted earnings were $229 million, excluding notable items. The result was impacted by market conditions in Chile, resulting in a negative encaje return. What stands out here is our momentum. Adjusted PFOs grew 14% on a constant currency basis, led by Mexico and Chile. As the number one life insurer in Latin America, we reach about 30 million customers across group, agency, and direct channels, including our Xcelerator embedded insurance platform. In EMEA, adjusted earnings were $114 million, excluding notable items, up 30%. This was above the $90 million-$100 million quarterly run rate we have discussed, driven by volume growth. Adjusted PFOs grew 17% on a constant currency basis. Embedded insurance is working here too.
Our new multi-market partnership with Revolut, one of Europe's largest digital banks, offers a seamless, integrated customer experience. This is part of a larger story on MetLife being able to leverage its capabilities on a global scale. We are applying the digital lessons we have learned and the capabilities and experience we have built in Latin America, in EMEA, and soon Asia as well, demonstrating the power of One MetLife. At MetLife Investment Management, or MIM, adjusted earnings were $63 million, up 9% and 19% year to date, reflecting the addition of PineBridge and sequential profit margin expansion. No single business carried the quarter. Group led on underwriting, RIS and Asia on investments, Latin America and EMEA on top-line growth. This is diversification at work, and it underscores the all-weather nature of our results.
Against a favorable backdrop for the life insurance industry, including higher rates, stable credit, and rising demand for retirement products, our strong capital position gives us multiple attractive avenues for growth. It all starts with our steady recurring capital generation and free cash flow, and our disciplined framework for deploying. Organic growth comes first, where we have structural advantages and can earn attractive risk-adjusted returns. We hold every dollar deployed to support new business to a strict return standard, and we track the value it creates, VNB, or the value of new business. We have done this consistently for more than a decade. At the start of this journey 10 years ago, we put $2.9 billion of capital to work at an internal rate of return of 12% and a payback period of eight years.
Fast-forward to last year, where we deployed $3.8 billion at an IRR of 19% and a payback of five years. More capital deployed at a higher IRR with a faster payback. That discipline has been compounding, and it is showing up in our rising return on equity. After funding attractive organic growth, we consider acquisitions, but only when they add a strategic capability and meet our stringent financial criteria. A deal has to earn at least as much as we earn by investing in our own business or buying back our shares. Beyond those opportunities, we consistently return excess capital to shareholders. in the third quarter, we repurchased $650 million of our common shares and another $265 million in October. Year to date, that brings total capital return to shareholders to roughly $3.5 billion through both buybacks and common stock dividends.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
13 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
